Capricor Therapeutics Cash Flow Statement (2010-2026) | CAPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-5.07M	-10.04M	-6.23M	-7.90M	-11.68M	-24.24M	-7.38M	-8.23M	-19.48M	-10.62M	-1.36M	-41.22M	-23.15M	-131.06M	-7.24M	-24.39M	-88.72M	-60.21M	-32.07M	-33.94M
Depreciation and Depletion (Quarter)	0.05M	0.06M	0.08M	0.09M	0.11M	0.14M	0.19M	0.23M	0.25M	0.28M	0.31M	0.33M	0.36M	0.36M	0.38M	0.41M	0.49M	0.49M	0.50M	0.53M
Share-based Compensation (Quarter)	0.71M	0.72M	0.78M	1.07M	1.16M	1.09M	1.15M	2.19M	1.62M	1.72M	1.86M	3.27M	2.15M	16.60M	-7.47M	0.26M	8.87M	4.25M		5.92M
Change in Interest Receivables (Quarter)
Cash from Operations (Quarter)	-4.51M	-3.34M	-5.63M	24.05M	-6.54M	-5.69M	-6.90M	4.21M	-9.42M	-8.79M	-11.59M	-1.27M	-12.29M	-11.64M	-14.80M	-6.43M	-20.12M	-19.69M	-23.57M	-29.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.05M	0.06M	0.08M	0.09M	0.11M	0.14M	0.19M	0.23M	0.25M	0.28M	0.31M	0.33M	0.36M	0.36M	0.38M	0.41M	0.49M	0.49M	0.50M	0.53M
Change in Working Capital
Change in Account Payables (Quarter)	0.05M	0.12M	0.10M	-0.02M	-0.48M	-0.01M	0.01M	-0.07M	-89.00	0.00M	0.01M
Change in Accured Expenses (Quarter)	-0.35M	-0.31M	0.63M	0.41M	-0.40M	0.72M	0.98M	0.50M	-0.29M	1.66M	-0.54M	-0.00M	-0.08M	0.36M	1.66M	1.32M	1.53M	0.97M	2.17M	-3.08M
Other Working Capital Changes (Quarter)				30.00M		-1.59M	-0.96M	9.01M	-3.92M	-6.19M	-2.09M	-4.91M	-3.97M	-2.26M	-1.13M
Investing Activities
Capital Expenditures (Quarter)	0.32M	0.47M	0.37M	0.57M	0.18M	0.56M	0.69M	0.35M	0.14M	0.27M	0.56M	0.61M	0.06M	0.01M	0.49M	0.90M	0.29M	0.06M	1.66M	5.12M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)					14.01M	30.09M	38.41M	32.05M	24.75M	28.16M	19.64M	24.37M	30.85M	21.86M	16.72M	43.21M	76.00M	78.18M	63.21M	31.00M
Cash from Investing Activities (Quarter)	-0.32M	-0.47M	-0.37M	-0.63M	-35.41M	-4.18M	5.14M	-3.21M	6.46M	7.72M	-5.86M	-9.50M	14.70M	2.00M	-123.38M	23.89M	14.55M	15.95M	43.09M	-154.64M
Financing Activities
Other financing activities (Quarter)		0.01M	0.04M	0.03M	0.02M	0.00M	0.03M	0.00M	0.06M		0.00M			0.12M	0.25M	0.05M	0.02M	0.01M	11.78M	1.47M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	1.26M	1.45M	3.79M	5.57M	1.93M	2.64M	5.78M	1.76M	1.82M	1.26M	8.23M	10.63M	0.36M	0.46M	0.06M
Net Equity Issued and Repurchased (Quarter)	0.70M	9.40M	7.50M			1.88M	2.92M		2.13M	0.22M	23.16M	2.29M	1.99M	15.00M	80.84M				77.50M
Misc.
Cash from Financing Activities (Quarter)	1.04M	6.57M	0.04M	0.03M	0.02M	1.88M	2.95M	0.00M	2.19M	0.22M	23.17M	2.29M	2.07M	67.33M	81.09M	0.05M	0.02M	0.01M	248.82M	1.47M
Change in Cash (Quarter)	-3.80M	2.76M	-5.95M	23.45M	-41.94M	-7.98M	1.19M	1.00M	-0.77M	-0.85M	5.71M	-8.48M	4.47M	57.69M	-57.09M	17.51M	-5.55M	-3.73M	268.34M	-182.43M
Free Cash Flow (Quarter)	-4.84M	-3.81M	-6.00M	23.48M	-6.72M	-6.24M	-7.60M	3.86M	-9.55M	-9.06M	-12.15M	-1.88M	-12.35M	-11.65M	-15.29M	-7.33M	-20.41M	-19.74M	-25.23M	-34.38M
Net Cash Flow (Quarter)	-3.80M	2.76M	-5.95M	23.45M	-41.94M	-7.98M	1.19M	1.00M	-0.77M	-0.85M	5.71M	-8.48M	4.47M	57.69M	-57.09M	17.51M	-5.55M	-3.73M	268.34M	-182.43M

Research Tools

Developers

Capricor Therapeutics Cash Flow Statement (2010-2026) | CAPR

Research Tools

Developers

Capricor Therapeutics Cash Flow Statement (2010-2026) | CAPR

Create an account

Sign In

Reset Password